192 related articles for article (PubMed ID: 20362604)
1. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
[TBL] [Abstract][Full Text] [Related]
2. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
[TBL] [Abstract][Full Text] [Related]
3. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
[TBL] [Abstract][Full Text] [Related]
4. Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment.
Cook DA; Samarasekara CL; Wagstaff SC; Kinne J; Wernery U; Harrison RA
Toxicon; 2010 Sep; 56(4):596-603. PubMed ID: 20547172
[TBL] [Abstract][Full Text] [Related]
5. Production and preclinical assessment of camelid immunoglobulins against Echis sochureki venom from desert of Rajasthan, India.
Tanwar PD; Ghorui SK; Kochar SK; Singh R; Patil NV
Toxicon; 2017 Aug; 134():1-5. PubMed ID: 28528176
[TBL] [Abstract][Full Text] [Related]
6. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
[TBL] [Abstract][Full Text] [Related]
7. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera.
Harrison RA; Hasson SS; Harmsen M; Laing GD; Conrath K; Theakston RD
Toxicon; 2006 Mar; 47(3):364-8. PubMed ID: 16359717
[TBL] [Abstract][Full Text] [Related]
8. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the intrageneric neutralization scope of monospecific, bispecific/monogeneric and polyspecific/monogeneric antisera raised in horses immunized with sub-Saharan African snake venoms.
Sánchez A; Durán G; Segura Á; Herrera M; Vargas M; Villalta M; Arguedas M; Moscoso E; Umaña D; Gómez A; Gutiérrez JM; León G
PLoS Negl Trop Dis; 2024 May; 18(5):e0012187. PubMed ID: 38809847
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA
PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058
[TBL] [Abstract][Full Text] [Related]
11. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
Habib AG; Warrell DA
Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
[TBL] [Abstract][Full Text] [Related]
12. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM
Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756
[TBL] [Abstract][Full Text] [Related]
13. Effect of geographical variation of Echis ocellatus, Naja nigricollis and Bitis arietans venoms on their neutralization by homologous and heterologous antivenoms.
Sánchez A; Coto J; Segura Á; Vargas M; Solano G; Herrera M; Villalta M; Estrada R; Gutiérrez JM; León G
Toxicon; 2015 Dec; 108():80-3. PubMed ID: 26450770
[TBL] [Abstract][Full Text] [Related]
14. Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa.
Sánchez A; Segura Á; Vargas M; Herrera M; Villalta M; Estrada R; Wu F; Litschka-Koen T; Perry MA; Alape-Girón A; León G
Toxicon; 2017 Jan; 125():59-64. PubMed ID: 27890775
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM
Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.
Abubakar IS; Abubakar SB; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Theakston RD; Juszczak E; Alder N; Warrell DA;
PLoS Negl Trop Dis; 2010 Jul; 4(7):e767. PubMed ID: 20668549
[TBL] [Abstract][Full Text] [Related]
17. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
O'Leary MA; Isbister GK
Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis and management of snakebite in dogs--a southern African perspective.
Leisewitz AL; Blaylock RS; Kettner F; Goodhead A; Goddard A; Schoeman JP
J S Afr Vet Assoc; 2004 Mar; 75(1):7-13. PubMed ID: 15214688
[TBL] [Abstract][Full Text] [Related]
19. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.
Calvete JJ; Cid P; Sanz L; Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Theakston RD; Warrell DA; Gutiérrez JM
Am J Trop Med Hyg; 2010 Jun; 82(6):1194-201. PubMed ID: 20519622
[TBL] [Abstract][Full Text] [Related]
20. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
